These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 20205168

  • 61. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
    Xu S, Wang Y, Lu J, Xu J.
    Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
    [Abstract] [Full Text] [Related]

  • 62. Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure.
    Shaarawy M, Fathy SA, Mehany NL, Hindy OW.
    Clin Chem Lab Med; 2007 Nov; 45(11):1498-503. PubMed ID: 17970704
    [Abstract] [Full Text] [Related]

  • 63. Receptor Activator of Nuclear Factor κ-Β Ligand/Osteoprotegerin Axis in Adults with Hb S/β-Thalassemia and β-Thalassemia Trait.
    Tombak A, Boztepe B, Akbayir S, Dogru G, Sungur MA.
    Hemoglobin; 2020 Sep; 44(5):334-337. PubMed ID: 32873083
    [Abstract] [Full Text] [Related]

  • 64. [Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women].
    Seremak-Mrozikiewicz A, Tatuśko J, Drews K, Barlik M, Krajewski P, Spaczyński M, Mrozikiewicz PM.
    Ginekol Pol; 2009 May; 80(5):354-60. PubMed ID: 19548455
    [Abstract] [Full Text] [Related]

  • 65. VDR, RANKL and OPG polymorphisms as possible predisposing cofactors of postmenopausal osteoporosis: explorative study in Italian population.
    Mamolini E, Cervellati C, Greco P, Carrieri A, Massari L, Crivellari I, Scapoli C, Bonaccorsi G.
    Gynecol Endocrinol; 2017 Dec; 33(12):937-941. PubMed ID: 28488893
    [Abstract] [Full Text] [Related]

  • 66. Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
    Gifre L, Ruiz-Gaspà S, Carrasco JL, Portell E, Vidal J, Muxi A, Monegal A, Guañabens N, Peris P.
    Osteoporos Int; 2017 Sep; 28(9):2707-2715. PubMed ID: 28580511
    [Abstract] [Full Text] [Related]

  • 67. Analyses of RANK and RANKL in the post-GWAS context: functional evidence of vitamin D stimulation through a RANKL distal region.
    Yoskovitz G, Garcia-Giralt N, Rodriguez-Sanz M, Urreizti R, Guerri R, Ariño-Ballester S, Prieto-Alhambra D, Mellibovsky L, Grinberg D, Nogues X, Balcells S, Diez-Perez A.
    J Bone Miner Res; 2013 Dec; 28(12):2550-60. PubMed ID: 23744843
    [Abstract] [Full Text] [Related]

  • 68. Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.
    Ali R, Hammad A, El-Nahrery E, Hamdy N, Elhawary AK, Eid R.
    Lupus; 2019 Sep; 28(10):1233-1242. PubMed ID: 31403902
    [Abstract] [Full Text] [Related]

  • 69. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis.
    Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, Wang Y.
    Respir Res; 2011 Dec 16; 12(1):157. PubMed ID: 22176920
    [Abstract] [Full Text] [Related]

  • 70. Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis.
    Fernández-García D, Muñoz-Torres M, Mezquita-Raya P, de la Higuera M, Alonso G, Reyes-García R, Ochoa AS, Ruiz-Requena ME, Luna JD, Escobar-Jiménez F.
    J Endocrinol Invest; 2008 May 16; 31(5):416-21. PubMed ID: 18560259
    [Abstract] [Full Text] [Related]

  • 71. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75].
    Liu JM, Zhao HY, Ning G, Zhao YJ, Chen Y, Zhang LZ, Xu MY, Chen JL.
    Zhonghua Nei Ke Za Zhi; 2004 Jun 16; 43(6):447-50. PubMed ID: 15312444
    [Abstract] [Full Text] [Related]

  • 72. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B, Cortet C, Blanckaert F, d'Herbomez M, Marchandise X, Wémeau J-L, Decoulx M, Dewailly D.
    Osteoporos Int; 2001 Jun 16; 12(2):117-23. PubMed ID: 11303711
    [Abstract] [Full Text] [Related]

  • 73. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I, Alkhouli M, Gerard-O'Riley RL, Wright WB, Acton D, Gray AK, Patel B, Reilly AM, Lim KE, Robling AG, Econs MJ.
    Endocrinology; 2016 Feb 16; 157(2):722-36. PubMed ID: 26584014
    [Abstract] [Full Text] [Related]

  • 74. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L.
    Alcohol Alcohol; 2006 Feb 16; 41(3):261-6. PubMed ID: 16476762
    [Abstract] [Full Text] [Related]

  • 75. Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.
    Seguro LP, Casella CB, Caparbo VF, Oliveira RM, Bonfa A, Bonfa E, Pereira RM.
    Osteoporos Int; 2015 Feb 16; 26(2):459-67. PubMed ID: 25146092
    [Abstract] [Full Text] [Related]

  • 76. Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis.
    Mansour A, Aboeerad M, Qorbani M, Hashemi Taheri AP, Pajouhi M, Keshtkar AA, Larijani B, Mohajeri-Tehrani MR, Ganji MR.
    BMC Nephrol; 2018 Jul 11; 19(1):172. PubMed ID: 29996796
    [Abstract] [Full Text] [Related]

  • 77. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.
    Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E.
    Eur J Endocrinol; 2007 May 11; 156(5):555-62. PubMed ID: 17468191
    [Abstract] [Full Text] [Related]

  • 78. The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus.
    Akyay OZ, Canturk Z, Selek A, Cetinarslan B, Tarkun İ, Cakmak Y, Baydemir C.
    Medicine (Baltimore); 2023 Sep 29; 102(39):e35394. PubMed ID: 37773814
    [Abstract] [Full Text] [Related]

  • 79. The Relationship between Serum and Gene Expression Levels of RANK, RANKL and Osteoprotegerin Inflammatory Pathway with Unstable Angina: A Case-control Study.
    Farrokhian A, Miraftab M, Chenari M, Akbari H, Nikoueinejad H, Naimi E.
    Iran J Allergy Asthma Immunol; 2021 Aug 07; 20(4):473-483. PubMed ID: 34418901
    [Abstract] [Full Text] [Related]

  • 80. Association of PFN1 Gene Polymorphisms with Bone Mineral Density, Bone Turnover Markers, and Osteoporotic Fractures in Chinese Population.
    Wu Y, Wu S, Yang E, Zhang G, Shi Q, Liang J, Lian X, Xu J.
    Calcif Tissue Int; 2023 Aug 07; 113(2):207-215. PubMed ID: 37401976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.